vault backup: 2026-04-05 15:37:59
This commit is contained in:
Yanxin Lu
316
documents/medical/pacific/jiang_血检.md
Normal file
316
documents/medical/pacific/jiang_血检.md
Normal file
@@ -0,0 +1,316 @@
|
||||
---
|
||||
type: lab-results
|
||||
category: blood-work
|
||||
person: Jiang, Erica (Xuewei)
|
||||
date: 2025-03-06
|
||||
provider: Erica T. Wang, MD
|
||||
source: jiang_血检.pdf
|
||||
---
|
||||
|
||||
# Blood Tests - Erica Jiang
|
||||
|
||||
**Patient:** ERICA Jiang | **DOB:** 3/13/1993 | **MRN:** 203300739 | **PCP:** No Pcp | **Legal Name:** Xuewei Jiang
|
||||
|
||||
**Source:** My CS-Link - Test Details (https://mycslink.cedars-sinai.org/mycslink/app/test-results/details)
|
||||
|
||||
---
|
||||
|
||||
## ANTI-MULLERIAN HORMONE (AMH), SERUM
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Unit | Normal Range |
|
||||
|------|-------|------|--------------|
|
||||
| Anti-Mullerian Hormone (AMH) | 2.119 | ng/mL | 0.176 - 11.705 |
|
||||
|
||||
### Interpretive Information: Anti-Mullerian Hormone
|
||||
|
||||
**FEMALE:**
|
||||
|
||||
| Age Group | Reference Range |
|
||||
|-----------|----------------|
|
||||
| 6 months - 14 years | 0.256 - 6.345 ng/mL |
|
||||
| 15-17 years | 0.861 - 10.451 ng/mL |
|
||||
| 18-29 years | 0.401 - 16.015 ng/mL |
|
||||
| 30-39 years | 0.176 - 11.705 ng/mL |
|
||||
| 40-45 years | 6.282 ng/mL or less |
|
||||
| 46-50 years | 0.064 ng/mL or less |
|
||||
| Post-menopausal | 0.003 ng/mL or less |
|
||||
|
||||
**MALE:**
|
||||
|
||||
| Age Group | Reference Range |
|
||||
|-----------|----------------|
|
||||
| 6-11 months | 56.677 - 495.299 ng/mL |
|
||||
| 1-6 years | 33.442 - 342.450 ng/mL |
|
||||
| 7-9 years | 20.245 - 189.781 ng/mL |
|
||||
| 10-12 years | 2.903 - 178.243 ng/mL |
|
||||
| 13 years and older | 2.079 - 30.656 ng/mL |
|
||||
|
||||
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
|
||||
|
||||
**Performed By:** ARUP Laboratories, 500 Chipeta Way, Salt Lake City, UT 84108
|
||||
**Laboratory Director:** Jonathan R. Genzen, MD, PhD
|
||||
**CLIA Number:** 46 D0523979
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 11, 2025 10:39 AM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## CHLAMYDIA (CT)/GONOCOCCUS (GC), NAA
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Normal Value |
|
||||
|------|-------|-------------|
|
||||
| Source | URINE | - |
|
||||
| C trachomatis Result | NEGATIVE | NEGATIVE |
|
||||
| N Gonorrhoeae Result | NEGATIVE | NEGATIVE |
|
||||
|
||||
Chlamydia trachomatis DNA, if present, could not be detected.
|
||||
|
||||
Neisseria gonorrhoeae DNA, if present, could not be detected.
|
||||
|
||||
A negative result does not preclude the presence of Chlamydia trachomatis and/or Neisseria gonorrhoeae infection because results depend on adequate specimen collection, absence of inhibitors, and sufficient DNA to be detected.
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Result date:** Mar 06, 2025 9:59 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## ESTRADIOL
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Unit |
|
||||
|------|-------|------|
|
||||
| Estradiol | <24 | pg/mL |
|
||||
|
||||
### Estradiol Reference Range
|
||||
|
||||
| Group | Reference Range |
|
||||
|-------|----------------|
|
||||
| Adult Males | 11-44 pg/mL |
|
||||
| Normal Menstruating Females - Follicular Phase | 21-251 pg/mL |
|
||||
| Normal Menstruating Females - Mid-Cycle Phase | 38-649 pg/mL |
|
||||
| Normal Menstruating Females - Luteal Phase | 21-312 pg/mL |
|
||||
| Postmenopausal Females not on Hormone Replacement Therapy | <28 pg/mL |
|
||||
|
||||
Patients treated with Mifepristone should NOT be tested with the ARCHITECT or ALINITY I Estradiol assay for up to two weeks based on information available regarding Mifepristone's bioavailability.
|
||||
|
||||
If the patient is on aromatase inhibitors there is a potential for positive interference. Please use an alternate methodology such as liquid chromatography mass spectrometry (LC/MS).
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 06, 2025 2:33 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## FSH
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Unit |
|
||||
|------|-------|------|
|
||||
| Follicle Stimulating Hormone | 5.9 | MIU/ML |
|
||||
|
||||
### FSH Reference Range
|
||||
|
||||
| Group | Reference Range |
|
||||
|-------|----------------|
|
||||
| Males | 1.0 to 12.0 mIU/mL |
|
||||
| Normally Menstruating Females - Follicular Phase | 3.0 to 8.0 mIU/mL |
|
||||
| Normally Menstruating Females - Mid Cycle Phase | 2.6 to 16.7 mIU/mL |
|
||||
| Normally Menstruating Females - Luteal Phase | 1.4 to 5.5 mIU/mL |
|
||||
| Post Menopausal | 26.7 to 133.4 mIU/mL |
|
||||
|
||||
Reference interval adopted from Abbott Laboratories.
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 06, 2025 2:33 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## HEPATITIS B SURFACE ANTIGEN
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Normal Value |
|
||||
|------|-------|-------------|
|
||||
| Hepatitis B Surface Antigen | NEG | NEG |
|
||||
|
||||
NOTE: Testing method for Hep B Surface Ag is CMIA performed on the Abbott Alinity.
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 06, 2025 2:40 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## HEPATITIS C ANTIBODY
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Unit | Normal Value |
|
||||
|------|-------|------|-------------|
|
||||
| Hepatitis C Antibody | 0.10 | S/CO | <0.80 S/CO |
|
||||
|
||||
Results for Anti-HCV are now reported using signal-to-cutoff (S/CO) ratio.
|
||||
|
||||
### Interpretation
|
||||
|
||||
| S/CO Ratio | Interpretation |
|
||||
|------------|---------------|
|
||||
| >= 1.00 | POSITIVE |
|
||||
| 0.80 to 0.99 | INTERMEDIATE |
|
||||
| 0.00 to 0.79 | NEGATIVE |
|
||||
|
||||
To reduce the incidence of false positive results, the CDC recommends that all S/CO ratios between 1.00 and 4.99 be confirmed with additional PCR testing.
|
||||
|
||||
NOTE: Testing method for Hepatitis C Antibody is CMIA performed on the Abbott Alinity.
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 06, 2025 2:30 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## HIV ANTIGEN/ANTIBODY COMBO TEST
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Normal Value |
|
||||
|------|-------|-------------|
|
||||
| HIV Ag/Ab Combo | NEG | NEG |
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 06, 2025 2:30 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## TREPONEMA PALLIDUM ANTIBODIES, REFLEX TO CONFIRM
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value | Normal Value |
|
||||
|------|-------|-------------|
|
||||
| Syphilis, T. Pallidum Interpretation | NONREACTIVE | NONREACTIVE |
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Specimens:** Blood (Blood)
|
||||
**Result date:** Mar 06, 2025 2:29 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## TYPE & SCREEN
|
||||
|
||||
**Collected on:** Mar 06, 2025 9:55 AM
|
||||
|
||||
| Test | Value |
|
||||
|------|-------|
|
||||
| Specimen Expiration | 03/09/2025,2359 |
|
||||
| ABO/Rho(D) | B POSITIVE |
|
||||
| Antibody Screen | NEGATIVE |
|
||||
| Confirm ABO | Ref. Lab. Patient |
|
||||
| Female Rh Type | State law requires that the woman being tested be informed, by her physician, of her Rho(D) typing results. |
|
||||
|
||||
**Authorizing provider:** Erica T. Wang, MD
|
||||
**Collection date:** Mar 06, 2025 9:55 AM
|
||||
**Result date:** Mar 06, 2025 5:13 PM
|
||||
**Result status:** Final
|
||||
**Resulting lab:** CEDARS-SINAI MED CTR DEPT OF PATHOLOGY & LAB MEDICINE, 8700 Beverly Blvd., Los Angeles CA 90048
|
||||
**Lab director:** Anders H. Berg, M.D.-Ph.D.
|
||||
**CLIA #:** 05D0541033
|
||||
|
||||
---
|
||||
|
||||
## US PELVIS LIMITED
|
||||
|
||||
### Results
|
||||
|
||||
**Wang, Erica T., MD** 3/6/2025 10:30 AM
|
||||
**Attending:** Wang
|
||||
|
||||
**Probe Number:** F9
|
||||
**Ultrasound Route:** Transvaginal
|
||||
|
||||
**Patient name:** ERICA Jiang
|
||||
**MRN:** 203300739
|
||||
**Date of birth:** 3/13/1993
|
||||
**Patient's age:** 31 year old
|
||||
**Date of service:** 3/6/2025
|
||||
|
||||
### Right Ovary
|
||||
|
||||
| Parameter | Value |
|
||||
|-----------|-------|
|
||||
| Dimensions | 2.81 x 1.65 x 2.81 cm |
|
||||
| Comments | no cysts, LF 11.1 x 10.0 mm |
|
||||
| Follicle number | 7 |
|
||||
|
||||
### Left Ovary
|
||||
|
||||
| Parameter | Value |
|
||||
|-----------|-------|
|
||||
| Dimensions | 2.63 x 1.37 x 3.41 cm |
|
||||
| Comments | no cysts, LF 8.8 mm |
|
||||
| Follicle number | 4 |
|
||||
|
||||
### Uterus
|
||||
|
||||
| Parameter | Value |
|
||||
|-----------|-------|
|
||||
| Dimensions | 5.79 x 4.38 x 5.39 cm |
|
||||
| Endometrium thickness | 4.54 mm |
|
||||
|
||||
**Impression:** normal uterus, no ovarian cysts, AFC 7+4
|
||||
|
||||
**Holden performed and interpreted the ultrasound**
|
||||
|
||||
**Authorizing provider:** Marissa Holden
|
||||
**Result date:** Mar 06, 2025 10:00 AM
|
||||
**Result status:** Final
|
||||
Reference in New Issue
Block a user